{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:41:59Z","timestamp":1776775319131,"version":"3.51.2"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejmp.2026.105766","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:52:06Z","timestamp":1773820326000},"page":"105766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assessing the validity of simulation-based sensitivity analysis for patient-specific quality assurance devices"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9052-6510","authenticated-orcid":false,"given":"Riccardo","family":"Baldoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Kry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0717-4981","authenticated-orcid":false,"given":"Andrea","family":"Bruschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Ghirelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Pini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8740-1039","authenticated-orcid":false,"given":"Serenella","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9332-5351","authenticated-orcid":false,"given":"Marco","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmp.2026.105766_b0005","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1118\/1.3238104","article-title":"IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119","volume":"36","author":"Ezzell","year":"2009","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105766_b0010","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1118\/1.3514120","article-title":"Dosimetry tools and techniques for IMRT","volume":"38","author":"Low","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105766_b0015","doi-asserted-by":"crossref","unstructured":"Miften M, Olch A, Mihailidis D, Moran J, Pawlicki T, Molineu A et al. Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218. Med Phys. 2018; 45:e53-e83. doi: 10.1002\/mp.12810.","DOI":"10.1002\/mp.12810"},{"key":"10.1016\/j.ejmp.2026.105766_b0020","doi-asserted-by":"crossref","first-page":"S671","DOI":"10.1016\/S0167-8140(21)01292-5","article-title":"PO-1274: variations in IMRT demand and delivery across England","volume":"152","author":"Mee","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2026.105766_b0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/acm2.12885","article-title":"Survey results of 3D-CRT and IMRT quality assurance practice","volume":"21","author":"Mehrens","year":"2020","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ejmp.2026.105766_b0030","doi-asserted-by":"crossref","first-page":"e865","DOI":"10.1002\/mp.16536","article-title":"AAPM task group report 307: use of EPIDs for patient-specific IMRT and VMAT QA","volume":"50","author":"Dogan","year":"2023","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105766_b0035","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ijrobp.2017.03.049","article-title":"Treatment planning system calculation errors are present in most imaging and radiation oncology core-Houston Phantom failures","volume":"98","author":"Kerns","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105766_b0040","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ijrobp.2014.08.334","article-title":"Pulliam KB et al institutional patient-specific IMRT QA does not predict unacceptable plan delivery","volume":"90","author":"Kry","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105766_b0045","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1002\/mp.13638","article-title":"Independent recalculation outperforms traditional measurement-based IMRT QA methods in detecting unacceptable plans","volume":"46","author":"Kry","year":"2019","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105766_b0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.radonc.2020.05.014","article-title":"Estimating dose delivery accuracy in stereotactic body radiation therapy: a review of in-vivo measurement methods","volume":"149","author":"Esposito","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2026.105766_b0055","doi-asserted-by":"crossref","unstructured":"Lehmann J et al SEAFARER \u2013 A new concept for validating radiotherapy patient specific QA for clinical trials and clinical practice, Radiother Oncol 171, 2022, 121-128, doi: 10.1016\/j.radonc.2022.04.019.","DOI":"10.1016\/j.radonc.2022.04.019"},{"key":"10.1016\/j.ejmp.2026.105766_b0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1120\/jacmp.v10i1.2915","article-title":"On the sensitivity of patient-specific IMRT QA to MLC positioning errors","volume":"10","author":"Yan","year":"2009","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ejmp.2026.105766_b0065","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1118\/1.4943953","article-title":"IMRT QA: Selecting gamma criteria based on error detection sensitivity","volume":"43","author":"Steers","year":"2016","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105766_b0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mp.13265","article-title":"Site-specific alert criteria to detect patient-related errors with 3D EPID transit dosimetry","volume":"46","author":"Olaciregui-Ruiz","year":"2019","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105766_b0075","doi-asserted-by":"crossref","unstructured":"Brooks F, Hussein M et al Developing reference plans for evaluating global clinical trials credentialing and PSQA systems JACPM 2025.","DOI":"10.1002\/acm2.70113"},{"key":"10.1016\/j.ejmp.2026.105766_b0080","article-title":"A commissioning protocol for portal imaging-based radiotherapy in vivo dosimetry systems","volume":"32","author":"Esposito","year":"2024","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ejmp.2026.105766_b0085","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s13246-018-0693-0","article-title":"Characterization of EPID software for VMAT transit dosimetry","volume":"41","author":"Esposito","year":"2018","journal-title":"Australas Phys Eng Sci Med"},{"key":"10.1016\/j.ejmp.2026.105766_b0090","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.3390\/app112210715","article-title":"A validation method for EPID in vivo dosimetry algorithms","volume":"11","author":"Esposito","year":"2021","journal-title":"Appl Sci"},{"key":"10.1016\/j.ejmp.2026.105766_b0095","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00066-023-02081-x","article-title":"The role of EPID in vivo dosimetry in the risk management of stereotactic lung treatments","volume":"199","author":"Esposito","year":"2023","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ejmp.2026.105766_b0100","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.14156","article-title":"Is it still necessary to perform measured based pre-treatment patient-specific QA for SRS HyperArc treatments?","volume":"25","author":"Cavalli","year":"2024","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ejmp.2026.105766_b0105","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1088\/1361-6560\/aa590a","article-title":"A model-based 3D patient-specific pre-treatment QA method for VMAT using the EPID","volume":"62","author":"McCowan","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105766_b0110","doi-asserted-by":"crossref","first-page":"0421031","DOI":"10.1118\/1.4795757","article-title":"ROC analysis in patient specific quality assurance","volume":"40","author":"Carlone","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105766_b0115","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1118\/1.3533900","article-title":"Quality assurance of volumetric modulated arc therapy: evaluation and comparison of different dosimetric systems","volume":"38","author":"Masi","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105766_b0120","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1118\/1.4711755","article-title":"On using 3D \u03b3\u2010analysis for IMRT and VMAT pretreatment plan QA","volume":"39","author":"Wu","year":"2012","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105766_b0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/mp.17468","article-title":"Which failures do patient\u2010specific quality assurance systems need to catch?","volume":"52","author":"O'Daniel","year":"2025","journal-title":"Med Phys"}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:48:05Z","timestamp":1776772085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179726000530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":25,"alternative-id":["S1120179726000530"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105766","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the validity of simulation-based sensitivity analysis for patient-specific quality assurance devices","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105766"}}